B cells: The old new players in reproductive immunology

Frontiers in Immunology

Volumn 5, Issue JUN, 2014, Pages

  Fettke, Franziska ^a   Schumacher, Anne ^a   Costa, Serban Dan ^a   Zenclussen, Ana Claudia ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Autoantibodies; B cells; B10 cells; Breg; IL 10; Pregnancy

Indexed keywords

EID: 84905647314     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00285     Document Type: Review

References (125)

1. Kantha SS. A centennial review; the 1890 tetanus antitoxin paper of von Behring and Kitasato and the related developments. Keio J Med (1991) 40(1):35-9. doi: 10.2302/kjm.40.35
2. Murphy JB, Morton JJ. The lymphocyte as a factor in natural and induced resistance to transplanted cancer. Proc Natl Acad Sci U S A (1915) 1(7):435-7. doi:10.1073/pnas.1.7.435
3. Jerne NK. The natural-selection theory of antibody formation. Proc Natl Acad Sci U S A (1955) 41(11):849-57. doi:10.1073/pnas.41.11.849
4. Burnet FM. A modification of Jerne's theory of antibody production using the concept of clonal selection. CA Cancer J Clin (1976) 26(2):119-21. doi:10.3322/canjclin.26.2.119
5. Nossal GJ, Lederberg J. Antibody production by single cells. Nature (1958) 181(4620):1419-20. doi:10.1038/1811419a0
6. Ribatti D, Crivellato E, Vacca A. The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B cell lineage. Clin Exp Immunol (2006) 145(1):1-4. doi:10.1111/j.1365-2249.2006.03131.x
7. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 292(5819):154-6. doi:10.1038/292154a0
8. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 78(12):7634-8. doi:10.1073/pnas.78.12.7634
9. Bonifacino JS, Dasso M, Harford JB, Lippincott-Schwartz J, Yamada KM, editors. Current Protocols in Cell Biology. Hoboken, NJ: John Wiley & Sons, Inc. (2001).
10. Pathak S, Palan U. Immunology: Essential and Fundamental. 3rd ed. Tunbridge Wells: Anshan (2012).
11. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood (2008) 112(5):1570-80. doi:10.1182/blood-2008-02-078071
12. Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol (2013) 131(4):959-71. doi:10.1016/j.jaci.2013.01.046
13. Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Annu Rev Immunol (1993) 11:501-38. doi:10.1146/annurev.iy.11.040193.002441
14. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol (2008) 20(2):149-57. doi:10.1016/j.coi.2008.03.014
15. Janeway CA, Ron J, Katz ME. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol (1987) 138(4):1051-5.
16. Yanaba K, Bouaziz J, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity (2008) 28(5):639-50. doi:10.1016/j.immuni.2008.03.017
17. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser MB. Lymphocytes regulate dendritic cell (Dc) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med (2000) 192(4):475-82. doi:10.1084/jem.192.4.475
18. Lo-Man R. Regulatory B cells control dendritic cell functions. Immunotherapy (2011) 3(4 Suppl):19-20. doi:10.2217/imt.11.34
19. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol (2006) 176(2):705-10. doi:10.4049/jimmunol.176.2.705
20. Hardy RR, Hayakawa K, Haaijman J, Herzenberg LA. B-cell subpopulations identified by two-colour fluorescence analysis. Nature (1982) 297(5867):589-91. doi:10.1038/297589a0
21. Hardy RR. Isolation of Ly-1+/CD5+ B cells by cell sorting. Curr Protoc Immunol (2003) Chapter 3:Unit3.5B. doi:10.1002/0471142735.im0305bs55
22. Gatto D, Bachmann MF. Function of marginal zone B cells in antiviral B-cell responses. Crit Rev Immunol (2005) 25(4):331-42. doi:10.1615/CritRevImmunol.v25.i4.50
23. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol. Rev. (2004) 197:192-205.
24. Stall AM, Fariñas MC, Tarlinton DM, Lalor PA, Herzenberg LA, Strober S. Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand black-related) animals. Proc Natl Acad Sci U S A (1988) 85(19):7312-6. doi:10.1073/pnas.85.19.7312
25. Hayakawa K, Hardy RR, Herzenberg LA. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med (1985) 161(6):1554-68. doi:10.1084/jem.161.6.1554
26. Griffin DO, Rothstein TL. A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus. J Exp Med (2011) 208(13):2591-8. doi:10.1084/jem.20110978
27. Manohar V, Brown E, Leiserson WM, Chused TM. Expression of Lyt-1 by a subset of B lymphocytes. J Immunol (1982) 129(2):532-8.
28. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 157(1):202-18. doi:10.1084/jem.157.1.202
29. Kantor AB, Stall AM, Adams S, Herzenberg LA. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci U S A (1992) 89(8):3320-4. doi:10.1073/pnas.89.8.3320
30. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today (1999) 20(7):312-6. doi:10.1016/S0167-5699(99)01476-0
31. Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol (2005) 26(4):347-62. doi:10.1007/s00281-004-0182-2
32. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity (2005) 23(1):7-18. doi:10.1016/j.immuni.2005.04.011
33. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity (2004) 21(3):379-90. doi:10.1016/j.immuni.2004.06.019
34. Alugupalli KR, Gerstein RM. Divide and conquer: division of labor by B-1 B cells. Immunity (2005) 23(1):1-2. doi:10.1016/j.immuni.2005.07.001
35. Brossay L, Jullien D, Cardell S, Sydora BC, Burdin N, Modlin RL, et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol (1997) 159(3):1216-24.
36. Margni RA, Perdigón G, Abatángelo C, Gentile T, Binaghi RA. Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies. Immunology (1980) 41(3):681-6.
37. Haury M, Sundblad A, Grandien A, Barreau C, Coutinho A, Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol (1997) 27(6):1557-63. doi:10.1002/eji.1830270635
38. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 96(5):2250-5. doi:10.1073/pnas.96.5.2250
39. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol (1995) 7(6):812-8. doi:10.1016/0952-7915(95)80053-0
40. Förster I, Rajewsky K. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 17(4):521-8. doi:10.1002/eji.1830170414
41. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol (1989) 1(1):75-84. doi:10.1093/intimm/1.1.75
42. Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 81(8):2494-8. doi:10.1073/pnas.81.8.2494
43. Choi YS, Dieter JA, Rothaeusler K, Luo Z, Baumgarth N. B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol (2012) 42(1):120-9. doi:10.1002/eji.201141890
44. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 192(2):271-80. doi:10.1084/jem.192.2.271
45. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol (2000) 37(18):1141-9. doi:10.1016/S0161-5890(01)00025-6
46. Plater-Zyberk C, Maini RN, Lam K, Kennedy TD, Janossy G. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum (1985) 28(9):971-6. doi:10.1002/art.1780280903
47. Reap EA, Sobel ES, Cohen PL, Eisenberg RA. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J Exp Med (1993) 177(1):69-78. doi:10.1084/jem.177.1.69
48. Tsao BP, Ohnishi K, Cheroutre H, Mitchell B, Teitell M, Mixter P, et al. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol (1992) 149(1):350-8.
49. Casali P, Burastero SE, Balow JE, Notkins AL. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients. J Immunol (1989) 143(11):3476-83.
50. Vaughan JH. 1992 Joseph J. Bunim Lecture. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum (1993) 36(1):1-6. doi:10.1002/art.1780360102
51. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med (2000) 191(7):1253-8. doi:10.1084/jem.191.7.1253
52. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A (2000) 97(3):1184-9. doi:10.1073/pnas.97.3.1184
53. Witte T. IgM antibodies against dsDNA in SLE. Clin Rev Allergy Immunol (2008) 34(3):345-7. doi:10.1007/s12016-007-8046-x
54. Notley CA, Brown MA, Wright GP, Ehrenstein MR. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol (2011) 186(8):4967-72. doi:10.4049/jimmunol.1003021
55. Enghard P, Humrich JY, Chu VT, Grussie E, Hiepe F, Burmester G, et al. Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development. Eur J Immunol (2010) 40(6):1809-18. doi:10.1002/eji.200940050
56. Mantovani L, Wilder RL, Casali P. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol (1993) 151(1):473-88.
57. Murakami M, Yoshioka H, Shirai T, Tsubata T, Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol (1995) 7(5):877-82. doi:10.1093/intimm/7.5.877
58. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 10(4):451-61. doi:10.1016/S1074-7613(00)80045-X
59. Duan B, Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev (2006) 5(6):403-8. doi:10.1016/j.autrev.2005.10.007
60. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T. Rheumatoid factor secretion from human Leu-1+ B cells. Science (1987) 236(4797):81-3. doi:10.1126/science.3105057
61. Wolf SD, Dittel BN, Hardardottir F, Janeway CA. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 184(6):2271-8. doi:10.1084/jem.184.6.2271
62. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 3(10):944-50. doi:10.1038/ni833
63. Ray A, Basu S, Williams CB, Salzman NH, Dittel BN. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol (2012) 188(7):3188-98. doi:10.4049/jimmunol.1103354
64. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity (2002) 16(2):219-30. doi:10.1016/S1074-7613(02)00274-1
65. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol (2011) 178(2):735-43. doi:10.1016/j.ajpath.2010.10.022
66. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med (2003) 197(4):489-501. doi:10.1084/jem.20021293
67. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum (1994) 37(11):1647-55. doi:10.1002/art.1780371114
68. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 10(3):170-81. doi:10.1038/nri2711
69. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 147(11):3815-22.
70. Bouaziz J, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol (2010) 40(10):2686-91. doi:10.1002/eji.201040673
71. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 146(10):3444-51.
72. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood (2011) 117(2):530-41. doi:10.1182/blood-2010-07-294249
73. Inoue S, Leitner WW, Golding B, Scott D. Inhibitory effects of B cells on antitumor immunity. Cancer Res (2006) 66(15):7741-7. doi:10.1158/0008-5472.CAN-05-3766
74. Shah S, Divekar AA, Hilchey SP, Cho H, Newman CL, Shin S, et al. Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. Int J Cancer (2005) 117(4):574-86. doi:10.1002/ijc.21177
75. Shlomchik WD. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science (1999) 285(5426):412-5. doi:10.1126/science.285.5426.412
76. Rowe V, Banovic T, MacDonald KP, Kuns R, Don AL, Morris ES, et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood (2006) 108(7):2485-92. doi:10.1182/blood-2006-04-016063
77. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 120(6):1836-47. doi:10.1172/JCI39933
78. Gentile T, Borel IM, Angelucci J, Miranda S, Margni RA. Preferential synthesis of asymmetric antibodies in rats immunized with paternal particulate antigens. Effect on pregnancy. J Reprod Immunol (1992) 22(2):173-83. doi:10.1016/0165-0378(92)90014-U
79. Margni RA, Parma EA, Cerone S, Erpelding A, Perdigón G. Agglutinating and non-agglutinating antibodies in rabbits inoculated with a particulate antigen (Salmonella typhimurium). Immunology (1983) 48(2):351-9.
80. Malan Borel I, Gentile T, Angelucci J, Pividori J, Guala MC, Binaghi RA, et al. IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol (1991) 20(2):129-40. doi:10.1016/0165-0378(91)90029-P
81. Eblen AC, Gercel-Taylor C, Shields LB, Sanfilippo JS, Nakajima ST, Taylor DD. Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil Steril (2000) 73(2):305-13. doi:10.1016/S0015-0282(99)00505-1
82. Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R. Asymmetric antibodies and pregnancy. Am J Reprod Immunol (2001) 45(5):289-94. doi:10.1111/j.8755-8920.2001.450504.x
83. Barrientos G, Fuchs D, Schröcksnadel K, Ruecke M, Garcia MG, Klapp BF, et al. Low levels of serum asymmetric antibodies as a marker of threatened pregnancy. J Reprod Immunol (2009) 79(2):201-10. doi:10.1016/j.jri.2008.11.002
84. Canellada A, Färber A, Zenclussen AC, Gentile T, Dokmetjian J, Keil A, et al. Interleukin regulation of asymmetric antibody synthesized by isolated placental B cells. Am J Reprod Immunol (2002) 48(4):275-82. doi:10.1034/j.1600-0897.2002.01125.x
85. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol (2009) 33(3):130-7. doi:10.1053/j.semperi.2009.02.010
86. Laresgoiti-Servitje E, Gómez-López N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update (2010) 16(5):510-24. doi:10.1093/humupd/dmq007
87. Maynard SE, Min J, Merchan J, Lim K, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 111(5):649-58. doi:10.1172/JCI17189
88. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab (2003) 88(5):2348-51. doi:10.1210/jc.2002-021942
89. Levine RJ, Maynard SE, Qian C, Lim K, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 350(7):672-83. doi:10.1056/NEJMoa031884
90. Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. Natl Med J India (2010) 23(2):77-81.
91. Zenclussen ML, Casalis PA, El-Mousleh T, Rebelo S, Langwisch S, Linzke N, et al. Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide. J Pathol (2011) 225(2):293-304. doi:10.1002/path.2946
92. Linzke N, Schumacher A, Woidacki K, Croy BA, Zenclussen AC. Carbon monoxide promotes proliferation of uterine natural killer cells and remodeling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice. Hypertension (2014) 63(3):580-8. doi:10.1161/HYPERTENSIONAHA.113.02403
93. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 103(7):945-52. doi:10.1172/JCI4106
94. Herse F, LaMarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol (2013) 69(4):413-8. doi:10.1111/aji.12072
95. Jensen F, Wallukat G, Herse F, Budner O, El-Mousleh T, Costa S, et al. CD19+CD5+ cells as indicators of preeclampsia. Hypertension (2012) 59(4):861-8. doi:10.1161/HYPERTENSIONAHA.111.188276
96. LaMarca B, Babbette D, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension (2005) 46(4):1022-5. doi:10.1161/01.HYP.0000175476.26719.36
97. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension (2008) 52(6):1161-7. doi:10.1161/HYPERTENSIONAHA.108.120881
98. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation (2002) 9(3):147-60. doi:10.1080/mic.9.3.147.160
99. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 101(20):2382-7. doi:10.1161/01.CIR.101.20.2382
100. Dechend R, Homuth V, Wallukat G, Müller DN, Krause M, Dudenhausen J, et al. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Investig (2006) 13(2):79-86. doi:10.1016/j.jsgi.2005.11.006
101. Zhou CC, Ahmad S, Mi T, Xia L, Abbasi S, Hewett PW, et al. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res (2007) 100(1):88-95. doi:10.1161/01.RES.0000254703.11154.18
102. Herse F, Staff AC, Hering L, Müller DN, Luft FC, Dechend R. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med (2008) 86(6):697-703. doi:10.1007/s00109-008-0332-4
103. LaMarca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, et al. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 54(4):905-9. doi:10.1161/HYPERTENSIONAHA.109.137935
104. Parrish MR, Murphy SR, Rutland S, Wallace K, Wenzel K, Wallukat G, et al. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens (2010) 23(8):911-6. doi:10.1038/ajh.2010.70
105. LaMarca B, Wallace K, Herse F, Wallukat G, Martin JN, Weimer A, et al. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension (2011) 57(4):865-71. doi:10.1161/HYPERTENSIONAHA.110.167569
106. Ng CT, O'Neil M, Walsh D, Walsh T, Veale DJ. Successful pregnancy after rituximab in a women with recurrent in vitro fertilisation failures and anti-phospholipid antibody positive. Ir J Med Sci (2009) 178(4):531-3. doi:10.1007/s11845-008-0265-5
107. Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Arch Dermatol (2007) 143(8):1033-8. doi:10.1001/archderm.143.8.1033
108. Fatourechi MM, el-Azhary RA, Gibson LE. Rituximab: applications in dermatology. Int J Dermatol (2006) 45(10):1143-55. doi:10.1111/j.1365-4632.2006.03007.x
109. Chambers SA, Isenberg D. Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases. Lupus (2005) 14(3):210-4. doi:10.1191/0961203305lu2138oa
110. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol (2009) 2(2):76-83.
111. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril (1996) 66(1):24-9.
112. Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction (2011) 141(6):715-24. doi:10.1530/REP-10-0360
113. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol (1993) 151(9):4562-73.
114. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med (1996) 184(2):539-48. doi:10.1084/jem.184.2.539
115. Svensson L, Arvola M, Sällström MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol (2001) 51(1):3-7. doi:10.1016/S0165-0378(01)00065-1
116. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol (2006) 177(7):4888-96. doi:10.4049/jimmunol.177.7.4888
117. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang XJ, Pennline K, et al. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J (1998) 12(2):189-97.
118. Robertson SA, Care AS, Skinner RJ. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod (2007) 76(5):738-48. doi:10.1095/biolreprod.106.056143
119. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliott JF, Elliot J, et al. IL-10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol (1995) 154(9):4261-8.
120. Gendron RL, Nestel FP, Lapp WS, Baines MG. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J Reprod Fertil (1990) 90(2):395-402. doi:10.1530/jrf.0.0900395
121. Berg DJ, Kühn R, Rajewsky K, Müller W, Menon S, Davidson N, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 96(5):2339-47. doi:10.1172/JCI118290
122. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol (2005) 175(6):4084-90. doi:10.4049/jimmunol.175.6.4084
123. Jensen F, Muzzio D, Soldati R, Fest S, Zenclussen AC. Regulatory B10 cells restore pregnancy tolerance in a mouse model. Biol Reprod (2013) 89(4):90. doi:10.1095/biolreprod.113.110791
124. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol (1998) 28(1):359-69. doi:10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4
125. Schumacher A, Wafula PO, Teles A, El-Mousleh T, Linzke N, Zenclussen ML, et al. Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells. PLoS One (2012) 7(8):e42301. doi:10.1371/journal.pone.0042301